{"Ticker": "ABBV", "Company": "AbbVie", "Sector": "Health Care", "Updated": "2022-04-06", "Rating": {"Date": "2022-04-06", "Rating": "Resumed", "Organization": "Morgan Stanley", "Rating_Change": "Overweight", "Target_Change": "$192"}}
{"Ticker": "ABMD", "Company": "Abiomed", "Sector": "Health Care", "Updated": "2022-04-06", "Rating": {"Date": "2022-04-06", "Rating": "Initiated", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform", "Target_Change": "$330"}}
{"Ticker": "AMP", "Company": "Ameriprise Financial", "Sector": "Financials", "Updated": "2022-04-06", "Rating": {"Date": "2022-04-06", "Rating": "Downgrade", "Organization": "Piper Sandler", "Rating_Change": "Neutral to Underweight", "Target_Change": "$325 to $310"}}
{"Ticker": "APTV", "Company": "Aptiv", "Sector": "Consumer Discretionary", "Updated": "2022-04-06", "Rating": {"Date": "2022-04-06", "Rating": "Upgrade", "Organization": "BofA Securities", "Rating_Change": "Underperform to Buy", "Target_Change": "$125 to $165"}}
{"Ticker": "BMY", "Company": "Bristol Myers Squibb", "Sector": "Health Care", "Updated": "2022-04-06", "Rating": {"Date": "2022-04-06", "Rating": "Resumed", "Organization": "Morgan Stanley", "Rating_Change": "Underweight", "Target_Change": "$64"}}
{"Ticker": "KMX", "Company": "CarMax", "Sector": "Consumer Discretionary", "Updated": "2022-04-06", "Rating": {"Date": "2022-04-06", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Neutral", "Target_Change": "$195 to $165"}}
{"Ticker": "EW", "Company": "Edwards Lifesciences", "Sector": "Health Care", "Updated": "2022-04-06", "Rating": {"Date": "2022-04-06", "Rating": "Initiated", "Organization": "Wolfe Research", "Rating_Change": "Outperform", "Target_Change": "$134"}}
{"Ticker": "EA", "Company": "Electronic Arts", "Sector": "Communication Services", "Updated": "2022-04-06", "Rating": {"Date": "2022-04-06", "Rating": "Resumed", "Organization": "BofA Securities", "Rating_Change": "Buy", "Target_Change": "$166"}}
{"Ticker": "LLY", "Company": "Eli Lilly & Co", "Sector": "Health Care", "Updated": "2022-04-06", "Rating": {"Date": "2022-04-06", "Rating": "Resumed", "Organization": "Morgan Stanley", "Rating_Change": "Overweight", "Target_Change": "$265 to $364"}}
{"Ticker": "FIS", "Company": "Fidelity National Information Services", "Sector": "Information Technology", "Updated": "2022-04-06", "Rating": {"Date": "2022-04-06", "Rating": "Initiated", "Organization": "Stephens", "Rating_Change": "Overweight", "Target_Change": "$125"}}
{"Ticker": "FISV", "Company": "Fiserv", "Sector": "Information Technology", "Updated": "2022-04-06", "Rating": {"Date": "2022-04-06", "Rating": "Initiated", "Organization": "Stephens", "Rating_Change": "Equal-Weight", "Target_Change": "$110"}}
{"Ticker": "GPN", "Company": "Global Payments", "Sector": "Information Technology", "Updated": "2022-04-06", "Rating": {"Date": "2022-04-06", "Rating": "Initiated", "Organization": "Stephens", "Rating_Change": "Overweight", "Target_Change": "$170"}}
{"Ticker": "IR", "Company": "Ingersoll Rand", "Sector": "Industrials", "Updated": "2022-04-06", "Rating": {"Date": "2022-04-06", "Rating": "Downgrade", "Organization": "Wolfe Research", "Rating_Change": "Outperform to Peer Perform", "Target_Change": ""}}
{"Ticker": "ISRG", "Company": "Intuitive Surgical", "Sector": "Health Care", "Updated": "2022-04-06", "Rating": {"Date": "2022-04-06", "Rating": "Initiated", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform", "Target_Change": "$315"}}
{"Ticker": "JNJ", "Company": "Johnson & Johnson", "Sector": "Health Care", "Updated": "2022-04-06", "Rating": {"Date": "2022-04-06", "Rating": "Resumed", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight", "Target_Change": "$173"}}
{"Ticker": "MKTX", "Company": "MarketAxess", "Sector": "Financials", "Updated": "2022-04-06", "Rating": {"Date": "2022-04-06", "Rating": "Downgrade", "Organization": "Raymond James", "Rating_Change": "Outperform to Mkt Perform", "Target_Change": ""}}
{"Ticker": "MRK", "Company": "Merck & Co.", "Sector": "Health Care", "Updated": "2022-04-06", "Rating": {"Date": "2022-04-06", "Rating": "Resumed", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight", "Target_Change": "$80"}}
{"Ticker": "OXY", "Company": "Occidental Petroleum", "Sector": "Energy", "Updated": "2022-04-06", "Rating": {"Date": "2022-04-06", "Rating": "Initiated", "Organization": "Stifel", "Rating_Change": "Buy", "Target_Change": "$84"}}
{"Ticker": "OGN", "Company": "Organon & Co.", "Sector": "Health Care", "Updated": "2022-04-06", "Rating": {"Date": "2022-04-06", "Rating": "Resumed", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight", "Target_Change": "$35"}}
{"Ticker": "PYPL", "Company": "PayPal", "Sector": "Information Technology", "Updated": "2022-04-06", "Rating": {"Date": "2022-04-06", "Rating": "Initiated", "Organization": "Stephens", "Rating_Change": "Equal-Weight", "Target_Change": "$135"}}
{"Ticker": "PFE", "Company": "Pfizer", "Sector": "Health Care", "Updated": "2022-04-06", "Rating": {"Date": "2022-04-06", "Rating": "Resumed", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight", "Target_Change": "$55"}}
{"Ticker": "RMD", "Company": "ResMed", "Sector": "Health Care", "Updated": "2022-04-06", "Rating": {"Date": "2022-04-06", "Rating": "Initiated", "Organization": "Wolfe Research", "Rating_Change": "Outperform", "Target_Change": "$280"}}
{"Ticker": "SYF", "Company": "Synchrony Financial", "Sector": "Financials", "Updated": "2022-04-06", "Rating": {"Date": "2022-04-06", "Rating": "Upgrade", "Organization": "Piper Sandler", "Rating_Change": "Neutral to Overweight", "Target_Change": "$48 to $49"}}
{"Ticker": "TTWO", "Company": "Take-Two Interactive", "Sector": "Communication Services", "Updated": "2022-04-06", "Rating": {"Date": "2022-04-06", "Rating": "Resumed", "Organization": "BofA Securities", "Rating_Change": "Buy", "Target_Change": "$213"}}
{"Ticker": "GWW", "Company": "W. W. Grainger", "Sector": "Industrials", "Updated": "2022-04-06", "Rating": {"Date": "2022-04-06", "Rating": "Upgrade", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform to Outperform", "Target_Change": ""}}
